Dynamics of HDL-Cholesterol Following a Post-Myocardial Infarction Cardiac Rehabilitation Program
Reviews in Cardiovascular Medicine · 13.01.2025 · 26 (1)
DOI: 10.31083/rcm25399 ↗Kurz gefasst
Fachartikel in der Zeitschrift Reviews in Cardiovascular Medicine, online erschienen am 13.01.2025. Verfasst von Carlos Bertolín-Boronat und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Hospital Clinico Universitario de Valencia, 46010 Valencia, Spain. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Fondos Europeos de Desarrollo Regional FEDER and Fondo Social Europeo Plus, Postgraduate contracts, Conselleria de Educación of the Generalitat Valenciana.
Abstract (Originalsprache)
Background
Exercise-based cardiac rehabilitation programs (CRP) are recommended for patients following acute coronary syndrome to potentially improve high-density lipoprotein cholesterol (HDL-C) levels and prognosis. However, not all patients reach target HDL-C levels. Here we analyze the dynamics and predictors of HDL-C increase during CRP in patients following ST-segment elevation myocardial infarction or occlusion myocardial infarction.
Methods
We conducted a prospective study of myocardial infarction patients who completed exercise-based Phase 2 CRP. Data was collected on clinical variables, cardiovascular risk factors, treatment goals, pharmacological therapy, and health outcomes through questionnaires at the beginning and at the end of Phase 2 CRP. Lipid profile analysis was performed before discharge, 4 to 6 weeks after discharge, and at the end of Phase 2 CRP. Changes in lipid profiles were evaluated, and predictors of failure to increase HDL-C levels were identified by binary logistic regression analysis.
Results
Our cohort comprised 121 patients (mean age 61.67 ± 10.97 years, 86.8% male, and 47.9% smokers before admission). A significant decrease in total cholesterol, triglycerides, and low-density lipoprotein cholesterol (LDL-C) were noted, along with an increase in HDL-C (43.87 ± 9.18 vs. 39.8 ± 10.03 mg/dL, p < 0.001). Patients achieving normal HDL-C levels (>40 mg/dL in men and >50 mg/dL in women) significantly increased from 34.7% at admission to 52.9% the end of Phase 2. Multivariable analysis revealed smoking history (hazard ratio [HR] = 0.35, 95% confidence interval [CI], 0.11–0.96, p = 0.04), increased reduction in total cholesterol (HR = 0.94, 95% CI, 0.89–0.98, p = 0.004), and increased reduction in LDL-C (HR = 0.94, 95% CI, 0.89–0.99, p = 0.01) were inversely associated with failure to increase HDL-C levels. Conversely, higher HDL-C before CRP (HR = 1.15, 95% CI, 1.07–1.23, p < 0.001) and increased lipoprotein (a) (HR = 1.01, 95% CI, 1–1.02, p = 0.04) predicted failure to increase HDL-C levels. No significant correlations were found with Mediterranean diet adherence, weekly physical activity, training modalities, or physical fitness parameters.
Conclusions
Participation in an exercise-based Phase 2 CRP led to mild but significant increases in HDL-C. Smoking history and patients experiencing substantial reductions in total cholesterol and LDL-C were more likely to experience HDL-C increases, unlike those with higher HDL-C and lipoprotein (a) levels before CRP.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Hospital Clinico Universitario de Valencia, 46010 Valencia, Spain.
- INCLIVA Health Research Institute, 46010 Valencia, Spain.
- Network Biomedical Research Center for Cardiovascular Diseases (CIBER-CV), 28029 Madrid, Spain.
- Department of Rehabilitation, Hospital Clinico Universitario de Valencia, 46010 Valencia, Spain.
- Hospital Clinico Universitario de Valencia, 46010 Valencia, Spain.
- Centre for Biomaterials and Tissue Engineering, Universitat Politècnica de València, 46022 Valencia, Spain.
ORCID-Profile: Héctor Merenciano-González, Víctor Marcos-Garcés, Nerea Pérez, Laura López-Bueno, Alfonso Payá Rubio, César Ríos-Navarro, Juan Sanchis
Förderung
- Instituto de Salud Carlos III, Fondos Europeos de Desarrollo Regional FEDER and Fondo Social Europeo Plus
- Postgraduate contracts
- Conselleria de Educación of the Generalitat Valenciana
- Instituto de Salud Carlos III and co-funding from Fondo Social Europeo Plus
- Conselleria de Innovación, Universidades, Ciencia y Sociedad Digital of the Generalitat Valenciana
- Conselleria de Educación – Generalitat Valenciana and co-funding from Fondo Social Europeo Plus
Zitieren
APA
Bertolín-Boronat, C., Merenciano-González, H., Marcos-Garcés, V., Martínez-Mas, M. L., Climent Alberola, J. I., Pérez, N., López-Bueno, L., Esteban-Argente, M. C., Valls Reig, M., Arizón Benito, A., Payá Rubio, A., Ríos-Navarro, C., de Dios, E., Gavara, J., Sanchis, J., & Bodi, V. (2025). Dynamics of HDL-Cholesterol Following a Post-Myocardial Infarction Cardiac Rehabilitation Program. Reviews in Cardiovascular Medicine, 26(1). https://doi.org/10.31083/rcm25399
Vancouver
Bertolín-Boronat C, Merenciano-González H, Marcos-Garcés V, Martínez-Mas ML, Climent Alberola JI, Pérez N, et al. Dynamics of HDL-Cholesterol Following a Post-Myocardial Infarction Cardiac Rehabilitation Program. Reviews in Cardiovascular Medicine. 2025;26(1). doi:10.31083/rcm25399
BibTeX
@article{BertolnBoronat2025,
author = {Bertolín-Boronat, Carlos and Merenciano-González, Héctor and Marcos-Garcés, Víctor and Martínez-Mas, María Luz and Climent Alberola, Josefa Inés and Pérez, Nerea and López-Bueno, Laura and Esteban-Argente, María Concepción and Valls Reig, María and Arizón Benito, Ana and Payá Rubio, Alfonso and Ríos-Navarro, César and de Dios, Elena and Gavara, Jose and Sanchis, Juan and Bodi, Vicente},
title = {Dynamics of HDL-Cholesterol Following a Post-Myocardial Infarction Cardiac Rehabilitation Program},
journal = {Reviews in Cardiovascular Medicine},
year = {2025},
volume = {26},
number = {1},
doi = {10.31083/rcm25399}
}
EUVIMED